The α3β4 subtype of nicotinic acetylcholine receptors (nAChRs) has been implicated in mediating nicotine reinforcement processes. AT-1001 has been recently described as a high-affinity and selective α3β4 nAChR antagonist that blocks nicotine self-administration in rats. The aim of this study was to investigate the mechanism of action underlying the nicotine-suppressive effects of AT-1001.
AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology
CIPPITELLI, Andrea;CICCOCIOPPO, Roberto;
2015-01-01
Abstract
The α3β4 subtype of nicotinic acetylcholine receptors (nAChRs) has been implicated in mediating nicotine reinforcement processes. AT-1001 has been recently described as a high-affinity and selective α3β4 nAChR antagonist that blocks nicotine self-administration in rats. The aim of this study was to investigate the mechanism of action underlying the nicotine-suppressive effects of AT-1001.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
British J Pharmacol 2015 p1834.pdf
accesso aperto
Descrizione: Free Full Text from Publisher
Tipologia:
Versione Editoriale
Licenza:
DRM non definito
Dimensione
913.92 kB
Formato
Adobe PDF
|
913.92 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
